Health Update: Hormone therapy
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A NEW approach to hormone replacement therapy that may reduce unwanted side-effects is being studied at the Margaret Pyke Centre in London. Women recruited to the project will still take oestrogen orally, but progestogen, the second hormone used in HRT, will be released by an intrauterine device rather than being taken orally.
Giving progestogen in IUD form may reduce the dose needed to protect women from the risk of endometrial cancer and reduce side-effects such as abdominal swelling and mood swings. Delivering the hormone in this way will also provide contraception for those who still need it, and reduce the heavy bleeding often suffered by women who are nearing the menopause.
Women in their forties who have menopausal symptoms but whose periods have not completely stopped, and who are interested in joining the project, should contact Dr Naomi Hampton, Margaret Pyke Centre, 15 Bateman Buildings, Soho Square, London W1V 5TW (071-734 9358).
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments